Profits from all product sales will be equally shared after deductions for marketing and manufacturing costs and third party royalties.The initial development efforts will be with QLT's proprietary light activated drug, benzoporphyrin derivative (BPD), a photosensitive dye currently in Phase I trials for treating a variety of diseases including cancer and psoriasis.In photodynamic therapy, a photo